First Patient Included in PET Imaging Study of HER2 Expression in Metastatic Breast Cancer

Dokument -

First Patient Included in PET Imaging Study of HER2 Expression in Metastatic Breast Cancer

Solna, Sweden, April 30, 2013. Affibody is pleased to announce that the first patient has been enrolled in a clinical study to evaluate ABY-025 for PET imaging of HER2 expression in subjects with metastatic breast cancer.
  • Licens: All rights reserved
    Innehållet får bara användas av Mynewsdesk. Det är alltså inte tillåtet för någon annan att ladda ner, kopiera, sprida eller på annat sätt använda Innehållet (annat än för privat bruk i den mån det följer av lag).
  • Filformat: .pdf

Kontakter

David Bejker

Presskontakt CEO

Relaterat innehåll

First Patient Included in PET Imaging Study of HER2 Expression in Metastatic Breast Cancer

Solna, Sweden, April 30, 2013. Affibody is pleased to announce that the first patient has been enrolled in a clinical study to evaluate ABY-025 for PET imaging of HER2 expression in subjects with metastatic breast cancer.